Scottsdale-based HonorHealth and Phoenix-based NeoLight LLC are working together to advance technologies and innovation in the newborn care market. Under this new agreement, HonorHealth Research Institute will assess NeoLight’s medical technologies, starting with NeoLight’s portable Skylife phototherapy treatment device used to treat jaundice in newborns.
NeoLight LLC received FDA clearance in October 2017 for its portable Skylife phototherapy device to treat jaundice in newborns. (Image courtesy of NEOLIGHT LLC)
Under this new agreement, HonorHealth Research Institute will assess NeoLight’s medical technologies, starting with NeoLight’s portable Skylife phototherapy treatment device used to treat jaundice in newborns.
Financial terms of the partnership were not disclosed.
Last fall, NeoLight received clearance from the U.S. Food and Drug Administration to begin marketing the device.
HonorHealth will spearhead clinical studies of the device and help look for ways to improve the technology, said Vivek Kopparthi, co-founder and CEO of NeoLight.
But this is only the beginning, he said, as NeoLight continues to develop other innovations around newborn care.
Mark Slater, vice president of research for HonorHealth and CEO of HonorHealth Research Institute, said he’s excited to watch the development of NeoLight.
“It has some real promise and we like to be a community resource to help that development,” Slater said. “Jaundice is a big problem. It’s very common in babies. It can be associated with other medical complications that put them at risk.”
Slater said HonorHealth has similar collaborative efforts with more than 80 companies from all over the world to help them advance their technologies.
“From our end, it gets these innovative technologies into our providers’ hands and for our patients to have access to that, many times, years before they would be readily available in the marketplace,” Slater said.
Slater said he’s thrilled to be working with a local spin-out from Arizona State University.
“We’re enthused to see a company with not just one innovation but a pipeline of innovations that we may be able to work together to improve health outcomes and hopefully cost effectiveness of care,” Slater said. “We can be more efficient and help more people with the resources.”